* 中国央企国药集团旗下的药品及医疗器械分销商--国药控股1099.HK周二早盘跌幅扩大至2.6%，报18.3港元，创2024年9月26日以来新低。
* 花旗在报告中表示，将国药控股目标价下调至24.2港元，将2025年、2026年的收入预测均下调2%，因医疗设备销售趋势和零售业务优化不及预期；将2025年/2026年的每股盈利预测均下调6%，因销售组合变动导致毛利率下降。
* 国药控股今年迄今大跌14%，同期恒生指数.HSI大幅上扬17.9%。
* 恒生综合行业指数 - 医疗保健业.HSCIH盘中一度跌1.2%。（完）
更多股市简讯请点选CN-CMN-HOT
(发稿 徐凯文；审校 张喜良)
((kaiwen.xu@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.